Form 8-K Panbela Therapeutics, For: Mar 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Panbela Therapeutics Inc. (PBLA) Receives Nasdaq Delisting Determination
March 7, 2024 6:13 AM ESTOn March 5, 2024, The Nasdaq Stock Market LLC (Nasdaq) notified Panbela Therapeutics Inc. (NASDAQ: PBLA) that the Nasdaq Hearings Panel (the Panel) has determined to delist the Companys common stock and that trading of the Companys securities will be suspended at the open of trading on March 7, 2024.... More
